TF and cancer: The variant risk allele A creates a new binding site for the YY1 TF, a positive regulator of AKT1. These discoveries emphasize the need to deepen investigations into how somatic mutations and SNPs affect silencer elements, holding the potential to unveil a more profound comprehension of their significance in the pathogenesis of cancer.